164 related articles for article (PubMed ID: 18497543)
1. High expression of KLK14 in prostatic adenocarcinoma is associated with elevated risk of prostate-specific antigen relapse.
Rabien A; Fritzsche F; Jung M; Diamandis EP; Loening SA; Dietel M; Jung K; Stephan C; Kristiansen G
Tumour Biol; 2008; 29(1):1-8. PubMed ID: 18497543
[TBL] [Abstract][Full Text] [Related]
2. KLK15 is a prognostic marker for progression-free survival in patients with radical prostatectomy.
Rabien A; Fritzsche FR; Jung M; Tölle A; Diamandis EP; Miller K; Jung K; Kristiansen G; Stephan C
Int J Cancer; 2010 Nov; 127(10):2386-94. PubMed ID: 20473923
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of the human kallikrein gene 14 (KLK14) in normal and cancerous prostatic tissues.
Yousef GM; Stephan C; Scorilas A; Ellatif MA; Jung K; Kristiansen G; Jung M; Polymeris ME; Diamandis EP
Prostate; 2003 Sep; 56(4):287-92. PubMed ID: 12858357
[TBL] [Abstract][Full Text] [Related]
4. mRNA overexpression of kallikrein-related peptidase 14 (KLK14) is an independent predictor of poor overall survival in chronic lymphocytic leukemia patients.
Kontos CK; Adamopoulos PG; Papageorgiou SG; Pappa V; Scorilas A
Clin Chem Lab Med; 2016 Feb; 54(2):315-24. PubMed ID: 26351937
[TBL] [Abstract][Full Text] [Related]
5. PYGOPUS2 expression in prostatic adenocarcinoma is a potential risk stratification marker for PSA progression following radical prostatectomy.
Kao KR; Popadiuk P; Thoms J; Aoki S; Anwar S; Fitzgerald E; Andrews P; Voisey K; Gai L; Challa S; He Z; Gonzales-Aguirre P; Simmonds A; Popadiuk C
J Clin Pathol; 2018 May; 71(5):402-411. PubMed ID: 28924059
[TBL] [Abstract][Full Text] [Related]
6. Prostate-specific antigen mRNA and protein levels in laser microdissected cells of human prostate measured by real-time reverse transcriptase-quantitative polymerase chain reaction and immuno-quantitative polymerase chain reaction.
Pinzani P; Lind K; Malentacchi F; Nesi G; Salvianti F; Villari D; Kubista M; Pazzagli M; Orlando C
Hum Pathol; 2008 Oct; 39(10):1474-82. PubMed ID: 18619642
[TBL] [Abstract][Full Text] [Related]
7. The kallikrein 14 gene is down-regulated by androgen receptor signalling and harbours genetic variation that is associated with prostate tumour aggressiveness.
Lose F; Lawrence MG; Srinivasan S; O'Mara T; Marquart L; Chambers S; Gardiner RA; Aitken JF; Spurdle AB; Batra J; Clements JA;
Biol Chem; 2012 Apr; 393(5):403-12. PubMed ID: 22505522
[TBL] [Abstract][Full Text] [Related]
8. Decreased RECK expression indicating proteolytic imbalance in prostate cancer is associated with higher tumor aggressiveness and risk of prostate-specific antigen relapse after radical prostatectomy.
Rabien A; Burkhardt M; Jung M; Fritzsche F; Ringsdorf M; Schicktanz H; Loening SA; Kristiansen G; Jung K
Eur Urol; 2007 May; 51(5):1259-66. PubMed ID: 16806661
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of vasoactive intestinal peptide receptors and cyclooxygenase-2 in human prostate cancer. Analysis of potential prognostic relevance.
Fernández-Martínez AB; Carmena MJ; Arenas MI; Bajo AM; Prieto JC; Sánchez-Chapado M
Histol Histopathol; 2012 Aug; 27(8):1093-101. PubMed ID: 22763881
[TBL] [Abstract][Full Text] [Related]
10. Steroid hormone regulation and prognostic value of the human kallikrein gene 14 in ovarian cancer.
Yousef GM; Fracchioli S; Scorilas A; Borgoño CA; Iskander L; Puopolo M; Massobrio M; Diamandis EP; Katsaros D
Am J Clin Pathol; 2003 Mar; 119(3):346-55. PubMed ID: 12645335
[TBL] [Abstract][Full Text] [Related]
11. Expression of human Kallikrein 14 (KLK14) in breast cancer is associated with higher tumour grades and positive nodal status.
Fritzsche F; Gansukh T; Borgoño CA; Burkhardt M; Pahl S; Mayordomo E; Winzer KJ; Weichert W; Denkert C; Jung K; Stephan C; Dietel M; Diamandis EP; Dahl E; Kristiansen G
Br J Cancer; 2006 Feb; 94(4):540-7. PubMed ID: 16434994
[TBL] [Abstract][Full Text] [Related]
12. Global expression of AMACR transcripts predicts risk for prostate cancer - a systematic comparison of AMACR protein and mRNA expression in cancerous and noncancerous prostate.
Alinezhad S; Väänänen RM; Ochoa NT; Vertosick EA; Bjartell A; Boström PJ; Taimen P; Pettersson K
BMC Urol; 2016 Feb; 16():10. PubMed ID: 26928323
[TBL] [Abstract][Full Text] [Related]
13. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
Zhao Z; Liu J; Li S; Shen W
Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
[TBL] [Abstract][Full Text] [Related]
14. Quantitative RT-PCR analysis and immunohistochemical localization of the kallikrein-related peptidases 13 and 14 in lung.
Planque C; Bléchet C; Ayadi-Kaddour A; Heuzé-Vourc'h N; Dumont P; Guyétant S; Diamandis EP; El Mezni F; Courty Y
Biol Chem; 2008 Jun; 389(6):781-6. PubMed ID: 18627302
[TBL] [Abstract][Full Text] [Related]
15. The molecular function of kallikrein-related peptidase 14 demonstrates a key modulatory role in advanced prostate cancer.
Kryza T; Bock N; Lovell S; Rockstroh A; Lehman ML; Lesner A; Panchadsaram J; Silva LM; Srinivasan S; Snell CE; Williams ED; Fazli L; Gleave M; Batra J; Nelson C; Tate EW; Harris J; Hooper JD; Clements JA
Mol Oncol; 2020 Jan; 14(1):105-128. PubMed ID: 31630475
[TBL] [Abstract][Full Text] [Related]
16. ADAM9 expression is a significant and independent prognostic marker of PSA relapse in prostate cancer.
Fritzsche FR; Jung M; Tölle A; Wild P; Hartmann A; Wassermann K; Rabien A; Lein M; Dietel M; Pilarsky C; Calvano D; Grützmann R; Jung K; Kristiansen G
Eur Urol; 2008 Nov; 54(5):1097-106. PubMed ID: 18061337
[TBL] [Abstract][Full Text] [Related]
17. Integrity and amplification of nucleic acids from snap-frozen prostate tissues from robotic-assisted laparoscopic and open prostatectomies.
Voss BL; Santiano K; Milano M; Mangold KA; Kaul KL
Arch Pathol Lab Med; 2013 Apr; 137(4):525-30. PubMed ID: 23544941
[TBL] [Abstract][Full Text] [Related]
18. Quantitative analysis of human kallikrein gene 14 expression in breast tumours indicates association with poor prognosis.
Yousef GM; Borgoño CA; Scorilas A; Ponzone R; Biglia N; Iskander L; Polymeris ME; Roagna R; Sismondi P; Diamandis EP
Br J Cancer; 2002 Nov; 87(11):1287-93. PubMed ID: 12439719
[TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of kallikrein 15 gene expression in prostate tissue.
Stephan C; Yousef GM; Scorilas A; Jung K; Jung M; Kristiansen G; Hauptmann S; Bharaj BS; Nakamura T; Loening SA; Diamandis E
J Urol; 2003 Jan; 169(1):361-4. PubMed ID: 12478190
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of reverse transcriptase polymerase chain reaction for prostate-specific antigen in men with hormone-refractory prostate cancer.
Kantoff PW; Halabi S; Farmer DA; Hayes DF; Vogelzang NA; Small EJ
J Clin Oncol; 2001 Jun; 19(12):3025-8. PubMed ID: 11408497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
